on OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
On August 28, 2026, Oxurion NV announced the receipt of a transparency notification from Atlas Special Opportunities II, LLC. According to the notification, as of August 5, 2026, Atlas held 28,009,477 shares, crossing under the 20% threshold of Oxurion's total outstanding shares, which numbered 140,734,891 at that time. This change was due to the sale of voting securities.
Oxurion, based in Leuven, Belgium, is listed on Euronext Brussels. The company focuses on building a technology-enabled clinical research and software platform. Their operations merge clinical expertise, software innovation, and proprietary data to aid various sponsors in pharmaceuticals, biotechnology, and medical devices.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news